Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. [Phase 4]
A Phase 4 trial evaluated aripiprazole as dual therapy in chronic stable schizophrenia or schizoaffective disorder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Switch Study of BMS-337039 in Schizophrenic Out-patients [Phase 4]
This entry notes the completion of a Phase 4 switch study of BMS-337039 in outpatients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
This document reports an observational study evaluating the efficacy and safety of risperidone long-acting injection for schizophrenia; the …
-
FDA approval · 2013-11-07FDA Approved: OLANZAPINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for OLANZAPINE from Jubilant Cadista Pharmaceuticals Inc. This is a routine regulatory action up…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia [NA]
A completed clinical trial evaluating repetitive transcranial magnetic stimulation (rTMS) for negative symptoms in schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine [Phase 2]
Phase 2 clinical trial evaluating treatment for iatrogenic weight gain and dyslipidemia caused by olanzapine in schizophrenia. The study was…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Risperidone Augmentation in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating risperidone augmentation in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: GlyT-1 Inhibitor Treatment for Refractory Schizophrenia [Phase 2]
Phase 2 clinical trial update reporting completion of testing for a GlyT-1 inhibitor in treatment-refractory schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects [Phase 1]
A Phase 1 trial testing whether adding naltrexone to olanzapine (Zyprexa) can reduce metabolic side effects in people with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
An update on the efficacy and safety of aripiprazole in patients with schizophrenia or bipolar disorder from a completed clinical trial.
-
FDA approval · 2013-10-22FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals.
-
FDA label_change · 2013-10-21FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA (olanzapine) from Eli Lilly and Company, resulting in labeling changes for the medic…
-
FDA approval · 2013-10-17FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for fluphenazine decanoate from Hikma Pharmaceuticals USA, indicating an approved modification t…
-
FDA approval · 2013-10-10FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal Consta (risperidone) submitted by Janssen Pharmaceuticals, Inc. The action approves ch…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With Schizophrenia [Phase 4]
Phase 4 trial evaluating the response to treatment and safety of Paliperidone Extended-Release in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial results evaluating safety, tolerability, and pharmacokinetics of an iloperidone depot formulation in patients with …
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication [Phase 4]
Phase 4 study comparing risperidone long-acting injectable with oral antipsychotics in people with schizophrenia who had poor medication adh…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Oral Aripiprazole Open-Label Rollover Study [Phase 3]
Open-label rollover Phase 3 trial of oral aripiprazole for schizophrenia has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Enhancing the Outcome of Skills Training for People With Schizophrenia [NA]
A clinical trial update about an enhanced skills training program for people with schizophrenia. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia [Phase 3]
Completed Phase 3 trial evaluating metabolic parameters of sertindole in patients with schizophrenia; the document is an update, but specifi…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Sertindole in Asian Patients With Schizophrenia [Phase 3]
A Phase 3 study of sertindole in Asian patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease [Phase 4]
Phase 4 safety study of Paliperidone ER in patients with liver disease has completed with results posted.
-
FDA approval · 2013-09-19FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for ziprasidone filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2013-09-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for ziprasidone hydrochloride from Apotex Corp., confirming a generic version of the antipsychotic. …
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: Exploratory Cognition Study of Sertindole in Patients With Schizophrenia [Phase 3]
A Phase 3 exploratory cognition study of sertindole in adults with schizophrenia has been completed.